Mannose-binding lectin deficiency is not associated with anti-Saccharomyces cerevisiae antibody in Korean Crohn's disease patients.

[1]  Y. Shoenfeld,et al.  Anti-Saccharomyces cerevisiae Autoantibodies in Autoimmune Diseases: from Bread Baking to Autoimmunity , 2013, Clinical Reviews in Allergy & Immunology.

[2]  M. Czerwionka-Szaflarska,et al.  Mannan-binding lectin deficiency in pediatric patients with inflammatory bowel disease , 2011, Scandinavian journal of gastroenterology.

[3]  Young Sook Park,et al.  Diagnostic utility of anti-Saccharomyces cerevisiae antibody (ASCA) and Interferon-γ assay in the differential diagnosis of Crohn's disease and intestinal tuberculosis. , 2011, Clinica chimica acta; international journal of clinical chemistry.

[4]  B. Ye,et al.  Association of CARD8 with inflammatory bowel disease in Koreans , 2011, Journal of Human Genetics.

[5]  G. Veres,et al.  Mannose-binding lectin level and deficiency is not associated with inflammatory bowel diseases, disease phenotype, serology profile, and NOD2/CARD15 genotype in a large Hungarian cohort. , 2010, Human immunology.

[6]  C. Bowlus,et al.  The geoepidemiology of autoimmune intestinal diseases. , 2010, Autoimmunity reviews.

[7]  E. Steinhagen-Thiessen,et al.  Is there a role for mannan-binding lectin in the diagnosis of inflammatory bowel disease? , 2010, Immunogenetics.

[8]  A. Schoepfer,et al.  Low Mannan-Binding Lectin Serum Levels Are Associated With Complicated Crohn's Disease and Reactivity to Oligomannan (ASCA) , 2009, The American Journal of Gastroenterology.

[9]  T. Molnár,et al.  New Serological Markers for Inflammatory Bowel Disease Are Associated With Earlier Age at Onset, Complicated Disease Behavior, Risk for Surgery, and NOD2/CARD15 Genotype in a Hungarian IBD Cohort , 2008, The American Journal of Gastroenterology.

[10]  Stefan Schreiber,et al.  Diagnostics of inflammatory bowel disease. , 2007, Gastroenterology.

[11]  A. Boldt,et al.  Association of deficiency for mannan‐binding lectin with anti‐mannan antibodies in Crohn's disease: A family study , 2007, Inflammatory bowel diseases.

[12]  R. Xavier,et al.  Unravelling the pathogenesis of inflammatory bowel disease , 2007, Nature.

[13]  J. H. Kim,et al.  Clinical significance of anti-Saccharomyces cerevisiae antibody (ASCA) in Korean patients with Crohn's disease and its relationship to the disease clinical course. , 2007, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[14]  C. O'Morain,et al.  Role of ASCA and the NOD2/CARD15 mutation Gly908Arg in predicting increased surgical costs in Crohn's disease patients: A project of the European Collaborative Study Group on Inflammatory Bowel Disease , 2007, Inflammatory bowel diseases.

[15]  Y. Shoenfeld,et al.  Cross‐Reactive Epitopes on β2‐Glycoprotein‐I and Saccharomyces cerevisiae in Patients with the Antiphospholipid Syndrome , 2007, Annals of the New York Academy of Sciences.

[16]  P. Mannon,et al.  The fundamental basis of inflammatory bowel disease. , 2007, The Journal of clinical investigation.

[17]  A. Boldt,et al.  Deficiency for mannan-binding lectin is associated with antibodies to Saccharomyces cerevisiae in patients with Crohn’s disease and their relatives , 2006, Gut.

[18]  N. Klein,et al.  Mannose‐binding lectin in innate immunity: past, present and future , 2006, Tissue antigens.

[19]  P. Rutgeerts,et al.  Mannan binding lectin (MBL) gene polymorphisms are not associated with anti-Saccharomyces cerevisiae (ASCA) in patients with Crohn’s disease , 2006, Gut.

[20]  C. Mullighan,et al.  Mannose‐binding lectin: biology and clinical implications , 2005, Internal medicine journal.

[21]  J. Satsangi,et al.  Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. , 2005, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[22]  R. Balicer,et al.  Anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease , 2005, Gut.

[23]  Hie-Lim Kim,et al.  Analysis of mannose-binding lectin 2 (MBL2) genotype and the serum protein levels in the Korean population. , 2005, Molecular immunology.

[24]  H. Drummond,et al.  Sero-Reactivity to Microbial Components in Crohn's Disease Is Associated with Disease Severity and Progression, but not NOD2/CARD15 Genotype , 2004, The American Journal of Gastroenterology.

[25]  F. Seibold,et al.  Genetic variants of the mannan-binding lectin are associated with immune reactivity to mannans in Crohn's disease. , 2004, Gastroenterology.

[26]  P. Garred,et al.  Mannose-binding lectin variant alleles and the risk of arterial thrombosis in systemic lupus erythematosus. , 2004, The New England journal of medicine.

[27]  B. Sands,et al.  A male with a pelvic mass , 2004, Gut.

[28]  W. Ip,et al.  Serum Mannose‐Binding Lectin Levels and mbl2 Gene Polymorphisms in Different Age and Gender Groups of Southern Chinese Adults , 2004, Scandinavian journal of immunology.

[29]  H. Drummond,et al.  Anti‐Saccharomyces cerevisiae antibodies (ASCA) in Crohn's disease are associated with disease severity but not NOD2/CARD15 mutations , 2004, Clinical and experimental immunology.

[30]  D. Chang,et al.  Epidemiology of inflammatory bowel disease in the Songpa‐Kangdong district, Seoul, Korea, 1986–2005: A KASID study , 2003, Inflammatory bowel diseases.

[31]  Jonathan Braun,et al.  Selected loss of tolerance evidenced by Crohn's disease-associated immune responses to auto- and microbial antigens. , 2002, Gastroenterology.

[32]  J. S. Kim,et al.  Diagnostic Role of Anti-Saccharomyces cerevisiae Mannan Antibodies Combined With Antineutrophil Cytoplasmic Antibodies in Patients With Inflammatory Bowel Disease , 2002, Diseases of the colon and rectum.

[33]  A. Voss,et al.  Association of mannose-binding lectin gene variation with disease severity and infections in a population-based cohort of systemic lupus erythematosus patients , 2001, Genes and Immunity.

[34]  A. Svejgaard,et al.  The influence of mannose binding lectin polymorphisms on disease outcome in early polyarthritis. TIRA Group. , 2001, The Journal of rheumatology.

[35]  M. Melbye,et al.  Acute respiratory tract infections and mannose-binding lectin insufficiency during early childhood. , 2001, JAMA.

[36]  P. Rutgeerts,et al.  Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease , 2001, American Journal of Gastroenterology.

[37]  P. Rutgeerts,et al.  Anti-Saccharomyces Cerevisiae Antibodies (ASCA), Phenotypes of IBD, and Intestinal Permeability: A Study in IBD Families , 2001, Inflammatory bowel diseases.

[38]  S. Targan,et al.  Marker antibody expression stratifies Crohn's disease into immunologically homogeneous subgroups with distinct clinical characteristics , 2000, Gut.

[39]  Malcolm W. Turner.  Mannose-binding lectin: the pluripotent molecule of the innate immune system. , 1996, Immunology today.

[40]  P. Jacquinot,et al.  Specific antibody response to oligomannosidic epitopes in Crohn's disease , 1996, Clinical and diagnostic laboratory immunology.

[41]  M. Turner,et al.  Mannose binding protein gene mutations associated with unusual and severe infections in adults , 1995, The Lancet.

[42]  S. Allan,et al.  Identification of a 200-kDa glycoprotein antigen of Saccharomyces cerevisiae. , 1991, Immunology letters.

[43]  M. Kerr,et al.  Antibody to Saccharomyces cerevisiae (bakers' yeast) in Crohn's disease. , 1988, BMJ.

[44]  L. Trouw,et al.  A role for mannose-binding lectin dysfunction in generation of autoantibodies in systemic lupus erythematosus. , 2005, Rheumatology.

[45]  J. S. Kim,et al.  [Frequency analysis of NOD2 gene mutations in Korean patients with Crohn's disease]. , 2005, The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi.

[46]  R. Dwek,et al.  Two edged role of mannose binding lectin in rheumatoid arthritis: a cross sectional study. , 2000, The Journal of rheumatology.